Kurita_2003_J.Geriatr.Psychiatry.Neurol_16_184

Reference

Title : The beneficial effect of donepezil on visual hallucinations in three patients with Parkinson's disease - Kurita_2003_J.Geriatr.Psychiatry.Neurol_16_184
Author(s) : Kurita A , Ochiai Y , Kono Y , Suzuki M , Inoue K
Ref : J Geriatr Psychiatry Neurol , 16 :184 , 2003
Abstract :

Visual hallucinations (VHs) are common psychiatric symptoms in patients with long-standing Parkinson's disease (PD). Treatment with neuroleptics or withdrawal of anti-PD drugs may improve VHs but will worsen motor dysfunctions. The authors report on 3 patients with long-standing PD who were treated with the cholinesterase inhibitor donepezil for the treatment of VHs. Each received a daily dose of 5 mg of donepezil, after reducing or discontinuing anti-PD medications had failed to relieve the VHs. In 2 patients (patient 1, 2), donepezil decreased VHs without worsening motor dysfunctions. In addition, the cognitive status of patient 2 improved. In patient 3, donepezil also resolved VHs, but delusions developed during treatment. After discontinuing donepezil, delusions disappeared and VHs reappeared. Donepezil may ameliorate visual hallucinations in PD patients, but controlled, double-blind trials are necessary to further clarify the effect of this drug on VHs in PD.

PubMedSearch : Kurita_2003_J.Geriatr.Psychiatry.Neurol_16_184
PubMedID: 12967063

Related information

Citations formats

Kurita A, Ochiai Y, Kono Y, Suzuki M, Inoue K (2003)
The beneficial effect of donepezil on visual hallucinations in three patients with Parkinson's disease
J Geriatr Psychiatry Neurol 16 :184

Kurita A, Ochiai Y, Kono Y, Suzuki M, Inoue K (2003)
J Geriatr Psychiatry Neurol 16 :184